Normobaric hyperoxia delays and attenuates early nitric oxide production in focal cerebral ischemic rats

Overproduction of neuronal nitric oxide synthase (nNOS)-derived NO is detrimental during cerebral ischemia. Normobaric hyperoxia (NBO) has been shown to be neuroprotective, extending the therapeutic time window for ischemic stroke, but the mechanism is not fully understood. In the present study, using a rat model of ischemic stroke, we investigated the effect of early NBO treatment on neuronal NO production. Male Sprague–Dawley rats were given normoxia (30% O2) or NBO (95% O2) during 10, 30, 60 or 90 min filament occlusion of the middle cerebral artery. NOx− (nitrite plus nitrate) and 3-nitrotyrosine were measured in the ischemic cortex. Ischemia caused a rapid increase in the production of NOx−, with a peak at 10 min after ischemia onset, then gradually declining to the baseline level at 60 min. NBO treatment delayed the NOx− production peak to 30 min and attenuated the total amount of NOx−. Ischemia also increased 3-nitrotyrosine formation, which was significantly reduced by NBO treatment. Inhibition of nNOS by pre-treatment with 7-nitroindazole had similar effect as NBO treatment on NOx− and 3-nitrotyrosine production, and when combined with NBO, no further reduction in NO production was observed. Furthermore, NBO treatment significantly decreased brain infarct volume. Taken together, our findings demonstrate that delaying and attenuating the early NO release from nNOS may be an important mechanism accounting for NBO's neuroprotection.

Research Highlights
► NBO treatment delays and attenuates the production of NOx− and 3-nitrotyrosine.
► Early NBO treatment inhibits NO release from nNOS.
► Reducing NO production is an important mechanism of neuroprotection by NBO.